Merus NV (MRUS)
48.36
+0.86
(+1.81%)
USD |
NASDAQ |
May 03, 16:00
48.50
+0.14
(+0.29%)
After-Hours: 20:00
Merus Free Cash Flow: -146.19M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -146.19M |
| September 30, 2023 | -142.49M |
| June 30, 2023 | -158.50M |
| March 31, 2023 | -151.16M |
| December 31, 2022 | -157.54M |
| September 30, 2022 | -156.85M |
| June 30, 2022 | -136.61M |
| March 31, 2022 | -126.42M |
| December 31, 2021 | -60.50M |
| September 30, 2021 | -53.33M |
| June 30, 2021 | -42.02M |
| March 31, 2021 | -36.59M |
| December 31, 2020 | -81.19M |
| September 30, 2020 | -76.47M |
| June 30, 2020 | -79.80M |
| March 31, 2020 | -76.94M |
| December 31, 2019 | -65.65M |
| Date | Value |
|---|---|
| September 30, 2019 | -58.76M |
| June 30, 2019 | -62.34M |
| March 31, 2019 | -48.28M |
| December 31, 2018 | -50.44M |
| September 30, 2018 | -49.32M |
| June 30, 2018 | -45.67M |
| March 31, 2018 | -54.90M |
| December 31, 2017 | -45.75M |
| September 30, 2017 | -42.08M |
| June 30, 2017 | -32.12M |
| March 31, 2017 | -27.07M |
| December 31, 2016 | -27.59M |
| September 30, 2016 | -26.93M |
| June 30, 2016 | -29.99M |
| March 31, 2016 | -28.11M |
| December 31, 2015 | -25.29M |
Free Cash Flow Range, Past 5 Years
-158.50M
Minimum
Jun 2023
-36.59M
Maximum
Mar 2021
-98.39M
Average
-79.80M
Median
Jun 2020
Free Cash Flow Benchmarks
| argenx SE | -- |
| uniQure NV | -153.08M |
| ProQR Therapeutics NV | 21.84M |
| Pharming Group | -18.77M |
| Pharvaris NV | -100.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -36.35M |
| Cash from Investing (Quarterly) | -2.117M |
| Cash from Financing (Quarterly) | 1.50M |
| Free Cash Flow Per Share (Quarterly) | -0.6282 |
| Free Cash Flow to Equity (Quarterly) | -36.32M |
| Free Cash Flow to Firm (Quarterly) | -36.32M |
| Free Cash Flow Yield | -5.86% |